BG108531A - Нови х...'...роарилни производни, 'яхно'о пол"-аван... и използван... - Google Patents
Нови х...'...роарилни производни, 'яхно'о пол"-аван... и използван... Download PDFInfo
- Publication number
- BG108531A BG108531A BG108531A BG10853104A BG108531A BG 108531 A BG108531 A BG 108531A BG 108531 A BG108531 A BG 108531A BG 10853104 A BG10853104 A BG 10853104A BG 108531 A BG108531 A BG 108531A
- Authority
- BG
- Bulgaria
- Prior art keywords
- piperazin
- dioxin
- dihydrobenzo
- ethylsulfanyl
- chloro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Addiction (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200101036 | 2001-06-29 | ||
PCT/DK2002/000435 WO2003002556A1 (en) | 2001-06-29 | 2002-06-27 | Novel heteroaryl derivatives, their preparation and use |
Publications (1)
Publication Number | Publication Date |
---|---|
BG108531A true BG108531A (bg) | 2004-08-31 |
Family
ID=8160598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG108531A BG108531A (bg) | 2001-06-29 | 2004-01-14 | Нови х...'...роарилни производни, 'яхно'о пол"-аван... и използван... |
Country Status (27)
Country | Link |
---|---|
US (2) | US20040248883A1 (ru) |
EP (1) | EP1399438B1 (ru) |
JP (1) | JP2004535449A (ru) |
KR (1) | KR20040019026A (ru) |
CN (1) | CN1310909C (ru) |
AT (1) | ATE312094T1 (ru) |
AU (1) | AU2002344949B2 (ru) |
BG (1) | BG108531A (ru) |
BR (1) | BR0210401A (ru) |
CA (1) | CA2451228A1 (ru) |
CZ (1) | CZ2004156A3 (ru) |
DE (1) | DE60207857T2 (ru) |
DK (1) | DK1399438T3 (ru) |
EA (1) | EA006203B1 (ru) |
ES (1) | ES2252471T3 (ru) |
HK (1) | HK1068622A1 (ru) |
HU (1) | HUP0400344A2 (ru) |
IL (1) | IL158828A0 (ru) |
IS (1) | IS2425B (ru) |
MX (1) | MXPA03011769A (ru) |
NO (1) | NO326514B1 (ru) |
NZ (1) | NZ529460A (ru) |
PL (1) | PL365249A1 (ru) |
SI (1) | SI1399438T1 (ru) |
SK (1) | SK652004A3 (ru) |
UA (1) | UA75407C2 (ru) |
WO (1) | WO2003002556A1 (ru) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ529461A (en) * | 2001-06-29 | 2005-09-30 | H | Novel indole derivatives |
DE60231507D1 (de) | 2001-07-20 | 2010-07-01 | Psychogenics Inc | Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten |
JP4741487B2 (ja) * | 2003-07-02 | 2011-08-03 | コーラス ファーマ,インコーポレイティド | アズトレオナムl−リジン及びそれを調製するための方法 |
US7160888B2 (en) | 2003-08-22 | 2007-01-09 | Warner Lambert Company Llc | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
JP2008521771A (ja) | 2004-11-26 | 2008-06-26 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 改良された抗精神病活性および抗不安症活性を有するイソキサゾリン−インドール誘導体 |
CN102822167A (zh) | 2010-01-04 | 2012-12-12 | 埃南蒂亚有限公司 | 用于制备利伐沙班的方法及其中间体 |
CN104672364A (zh) | 2010-04-12 | 2015-06-03 | 湖南石油化学株式会社 | 使用包含噻吩稠合的环戊二烯基配体的过渡金属化合物制备烯烃-二烯共聚物的方法 |
KR101384412B1 (ko) | 2010-04-12 | 2014-04-25 | 롯데케미칼 주식회사 | 티오펜-축합고리 사이클로펜타디에닐 리간드를 포함하는 전이금속 화합물을 사용한 폴리프로필렌의 제조방법 |
KR100986301B1 (ko) | 2010-04-12 | 2010-10-07 | 아주대학교산학협력단 | 테트라하이드로퀴놀린 유도체로부터 유래한 티오펜-축합고리 싸이클로펜타디에닐 4족 금속 화합물 및 이를 이용한 올레핀 중합 |
ES2596717T3 (es) | 2010-04-12 | 2017-01-11 | Lotte Chemical Corporation | Composición de catalizador para la polimerización de olefina y procedimiento de preparación de poliolefina usando la misma |
JP5567209B2 (ja) | 2010-04-12 | 2014-08-06 | ロッテ ケミカル コーポレーション | オレフィン重合用担持触媒およびこれを用いたポリオレフィンの製造方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2667068B1 (fr) * | 1990-09-26 | 1994-09-09 | Adir | Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
NZ529461A (en) | 2001-06-29 | 2005-09-30 | H | Novel indole derivatives |
-
2002
- 2002-06-27 CA CA002451228A patent/CA2451228A1/en not_active Abandoned
- 2002-06-27 EA EA200400102A patent/EA006203B1/ru not_active IP Right Cessation
- 2002-06-27 AT AT02742849T patent/ATE312094T1/de not_active IP Right Cessation
- 2002-06-27 UA UA20031211984A patent/UA75407C2/uk unknown
- 2002-06-27 HU HU0400344A patent/HUP0400344A2/hu unknown
- 2002-06-27 DE DE60207857T patent/DE60207857T2/de not_active Expired - Fee Related
- 2002-06-27 EP EP02742849A patent/EP1399438B1/en not_active Expired - Lifetime
- 2002-06-27 CZ CZ2004156A patent/CZ2004156A3/cs unknown
- 2002-06-27 SK SK65-2004A patent/SK652004A3/sk unknown
- 2002-06-27 AU AU2002344949A patent/AU2002344949B2/en not_active Ceased
- 2002-06-27 PL PL02365249A patent/PL365249A1/xx unknown
- 2002-06-27 BR BR0210401-6A patent/BR0210401A/pt not_active IP Right Cessation
- 2002-06-27 ES ES02742849T patent/ES2252471T3/es not_active Expired - Lifetime
- 2002-06-27 WO PCT/DK2002/000435 patent/WO2003002556A1/en active IP Right Grant
- 2002-06-27 MX MXPA03011769A patent/MXPA03011769A/es active IP Right Grant
- 2002-06-27 SI SI200230265T patent/SI1399438T1/sl unknown
- 2002-06-27 NZ NZ529460A patent/NZ529460A/en unknown
- 2002-06-27 JP JP2003508937A patent/JP2004535449A/ja active Pending
- 2002-06-27 KR KR10-2003-7017125A patent/KR20040019026A/ko active IP Right Grant
- 2002-06-27 US US10/482,764 patent/US20040248883A1/en not_active Abandoned
- 2002-06-27 IL IL15882802A patent/IL158828A0/xx unknown
- 2002-06-27 CN CNB028129946A patent/CN1310909C/zh not_active Expired - Fee Related
- 2002-06-27 DK DK02742849T patent/DK1399438T3/da active
-
2003
- 2003-11-10 IS IS7021A patent/IS2425B/is unknown
- 2003-12-18 NO NO20035673A patent/NO326514B1/no unknown
-
2004
- 2004-01-14 BG BG108531A patent/BG108531A/bg unknown
-
2005
- 2005-02-04 HK HK05100986A patent/HK1068622A1/xx not_active IP Right Cessation
-
2007
- 2007-06-05 US US11/758,511 patent/US7393845B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7393845B2 (en) | Heteroaryl derivates, their preparation and use | |
DK2937341T3 (en) | 4- (BENZYL) -PIPERAZINE-1-CARBOXYLIC ACID PHENYLAMIDE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF FATTY ACID HYDROLASE (FAAH) FOR TREATING ANALYSIS, PAIN AND OTHER CONDITIONS | |
US20160060231A1 (en) | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity | |
KR20000005505A (ko) | 피페리딘 및 피롤리딘 | |
TW200526630A (en) | Novel pyridine derivatives | |
AU2002344949A1 (en) | Novel heteroaryl derivatives, their preparation and use | |
JP2001520224A (ja) | 2−置換1,2−ベンジイソチアゾール誘導体およびそのセロトニン拮抗薬(5−ht1a、5−ht1b、5−ht1d)としての使用 | |
EP1399434B1 (en) | Novel indole derivatives | |
AU2002344950A1 (en) | Novel indole derivatives | |
KR100470691B1 (ko) | 시클로부타인돌카르복사미드 화합물, 이의 제조 방법 및이를 함유하는 약제 조성물 | |
AU2007200149A1 (en) | Vanilloid receptor ligands and their use in treatments |